Pneumocystis jirovecii pneumonia laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 24: Line 24:
'''E:''' Indirect immunofluorescence using monoclonal antibodies against Pneumocystis jirovecii.  Specimen from a patient with AIDS, seen in Georgia.
'''E:''' Indirect immunofluorescence using monoclonal antibodies against Pneumocystis jirovecii.  Specimen from a patient with AIDS, seen in Georgia.
<br clear="left"/>  
<br clear="left"/>  
===Molecular===
==Molecular==
[[Image:Agarose gel.jpg|left|thumb|200px|Agarose gel - PCR for Pneumocystis]]
[[Image:Agarose gel.jpg|left|thumb|200px|Agarose gel - PCR for Pneumocystis]]
Molecular methods for detection of P. jirovecii have shown very high sensitivity and specificity and constitute the gold standard for detection of this pathogen.
Molecular methods for detection of P. jirovecii have shown very high sensitivity and specificity and constitute the gold standard for detection of this pathogen.
Line 33: Line 33:
*Lane 1: Single step PCR amplification with the pAZ102-E/pAZ102-H primer pair1 - diagnostic band size: 346 bp.  
*Lane 1: Single step PCR amplification with the pAZ102-E/pAZ102-H primer pair1 - diagnostic band size: 346 bp.  
*Lane 2: Nested PCR amplification with the ITS nested PCR primers, 1724F/ITS2R (first round) and ITS1F/ITS2R1 (second round)2 -diagnostic band size: 550 bp.  
*Lane 2: Nested PCR amplification with the ITS nested PCR primers, 1724F/ITS2R (first round) and ITS1F/ITS2R1 (second round)2 -diagnostic band size: 550 bp.  
<br clear="left"/>  
<br clear="left"/>
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 18:56, 7 February 2012

Pneumonia Main Page

Pneumocystis jirovecii pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pneumocystis jirovecii pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pneumocystis jirovecii pneumonia laboratory tests On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pneumocystis jirovecii pneumonia laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pneumocystis jirovecii pneumonia laboratory tests

CDC on Pneumocystis jirovecii pneumonia laboratory tests

Pneumocystis jirovecii pneumonia laboratory tests in the news

Blogs on Pneumocystis jirovecii pneumonia laboratory tests

Pneumocystis jirovecii pneumonia

Risk calculators and risk factors for Pneumocystis jirovecii pneumonia laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The specific diagnosis is based on identification of P. jirovecii in bronchopulmonary secretions obtained as induced sputum or bronchoalveolar lavage (BAL) material. In situations where these two techniques cannot be used, transbronchial biopsy or open lung biopsy may prove necessary. Microscopic identification of P. jiroveci trophozoites and cysts is performed with stains that demonstrate either the nuclei of trophozoites and intracystic stages (such as Giemsa) or the cyst walls (such as the silver stains). In addition, immunofluorescence microscopy using monoclonal antibodies can identify the organisms with higher sensitivity than conventional microscopy.

Microscopic

Pneumocystis jirovecii trophozoites

A: Pneumocystis jirovecii trophozoites in bronchoalveolar lavage (BAL) material. Giemsa stain. The trophozoites are small (size: 1 to 5 µm), and only their nuclei, stained purple, are visible (arrows). AIDS patient seen in Atlanta, Georgia.

Pneumocystis jirovecii cysts

Pneumocystis jirovecii cysts

B: 3 cysts in bronchoalveolar material, Giemsa stain; the rounded cysts (size 4 to 7 µm) contain 6 to 8 intracystic bodies, whose nuclei are stained by Giemsa; the walls of the cysts are not stained; note the presence of several smaller, isolated trophozoites.
C: Cysts in lung tissue, silver stain; the walls of the cysts are stained black; the intracystic bodies are not visible with this stain; baby who died with pneumonia in California.

Pneumocystis jirovecii cysts


D: Pneumocystis jirovecii cysts in bronchoalveolar lavage material; silver stain; this greater magnification shows the irregular, saucer shape of the cysts.

Pneumocystis jirovecii

E: Indirect immunofluorescence using monoclonal antibodies against Pneumocystis jirovecii. Specimen from a patient with AIDS, seen in Georgia.

Molecular

Agarose gel - PCR for Pneumocystis

Molecular methods for detection of P. jirovecii have shown very high sensitivity and specificity and constitute the gold standard for detection of this pathogen.

A: Agarose gel (2%) analysis of PCR-amplified products from DNA extracted from a bronchoalveolar lavage (BAL) diagnostic specimen of a patient with pulmonary symptoms.

  • Lane S: Molecular base pair standard (100-bp ladder). Black arrows show the size of standard bands.
  • Lane 1: Single step PCR amplification with the pAZ102-E/pAZ102-H primer pair1 - diagnostic band size: 346 bp.
  • Lane 2: Nested PCR amplification with the ITS nested PCR primers, 1724F/ITS2R (first round) and ITS1F/ITS2R1 (second round)2 -diagnostic band size: 550 bp.


References

Template:WH Template:WS